| 注册
首页|期刊导航|中国临床保健杂志|利伐沙班抗凝治疗老年非瓣膜性心房颤动患者的效果

利伐沙班抗凝治疗老年非瓣膜性心房颤动患者的效果

刘晓红 杜雷 杨晨 冷闰杰

中国临床保健杂志2016,Vol.19Issue(4):397-399,3.
中国临床保健杂志2016,Vol.19Issue(4):397-399,3.DOI:10.3969/J.issn.1672-6790.2016.04.021

利伐沙班抗凝治疗老年非瓣膜性心房颤动患者的效果

The anticoagulant therapy for the elderly patients with nonvalvular atrial fibrillation with rivaroxaban

刘晓红 1杜雷 1杨晨 1冷闰杰1

作者信息

  • 1. 新疆克拉玛依市中心医院心血管内科,834000
  • 折叠

摘要

Abstract

Objective To investigate the effectiveness and safety of rivaroxaban for the elderly patients with nonvalvular atrial fibrillation.Methods 46 elderly patients with non valvular atrial fibrillationwererandomized were di-vided into control group (23 cases)and observation group (23 cases),The patients in the observation group were trea-ted with oral rivaroxaban (10mg/d)was on the basic of routine treatment,and in the control group the patients was trea-ted with oral warfarin,which the International standardization ratio were adjusted in the range between 1.8 and 2.5.The follow-up periodwas 6 months.The incidence of adverse events in the two groups of hemorrhage were compared.Results The incidence of stroke was 5.0% and 3.8% in the control group and the observation group,respectively,the differ-ence was not statistically significant (P >0.05);There were no serious and moderate bleeding in the two groups,The incidence of mild bleeding was 7.6% and 5.0% in the observation group and the control group,respectively,the differ-ence was not statistically significant (P >0.05).Conclusions The low-dose rivaroxaban treatment for the elderly pa-tients with non valvular atrial fibrillation is more effective and safety,and the effect of rivaroxaban and warfar for anti-coagulant is similar,which could significantly reduce the embolic events.

关键词

心房颤动/抗凝药/华法林/老年人

Key words

Atrial fibrillation/Anticoagulants/Warfarin/Aged

分类

医药卫生

引用本文复制引用

刘晓红,杜雷,杨晨,冷闰杰..利伐沙班抗凝治疗老年非瓣膜性心房颤动患者的效果[J].中国临床保健杂志,2016,19(4):397-399,3.

中国临床保健杂志

OACSTPCD

1672-6790

访问量0
|
下载量0
段落导航相关论文